Artificial intelligence helps UCSD scientists discover a biological process connected to the bowel disease, potentially ...
UC San Diego researchers combined artificial intelligence with molecular biology to unravel how immune cells in the gut ...
Crohn's disease and ulcerative colitis. Here's how to tell which one you have.
With about 190,000 people in the UK living with the disease and 10,000 diagnosed annually, the early treatment method could ...
Patients with refractory Crohn’s disease who previously received ustekinumab experienced clinical and endoscopic improvements ...
Duvakitug outperformed placebo at week 14 in endoscopic response and was well tolerated among patients with moderately to severely active Crohn’s disease, according to research presented at ACG Annual ...
The Brighterside of News on MSN
New AI model discovers two proteins that work together to prevent Crohn’s disease
Your gut harbors trillions of microbes which live in precarious harmony with your immune system. When that harmony is upset, ...
UC San Diego researchers have settled a decades-long debate surrounding the role of the first Crohn's disease gene to be ...
UC San Diego researchers have resolved a decades-long debate about the role of the first Crohn’s disease gene linked to an increased risk of developing the autoimmune condition. The human digestive ...
MedPage Today on MSN
Cell Therapy Tops Standard Care for Perianal Fistulas in Crohn's
PHOENIX -- An implantable autologous cell therapy led to higher remission rates compared with standard surgical care in ...
How Does Tremfya Work for Crohn's Disease? Tremfya is a type of medicine called a monoclonal antibody. It works by targeting a protein in your body called interleukin-23 (IL-23). IL-23 is a cytokine ...
Everyday Health on MSN
What Is Crohn’s Colitis?
Crohn’s colitis is a type of Crohn’s disease that only affects the colon, or large intestine. It differs from other types of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results